Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

NSE/ANTHEM stock hub

NSE/ANTHEM has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

NSE/ANTHEMis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

440.7B

National Stock Exchange of India

Market data

Live price

Current market quote for this ticker.

Current price

NSE/ANTHEM

In the news

Latest news · NSE/ANTHEM

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E66

P25 24.9P50 32.4P75 45.7

Trailing P/E91.5

P25 24.8P50 35.9P75 56.9

ROEn/a

P25 6.3P50 13.6P75 18.1

ROIC23.5

P25 4.1P50 10.3P75 17.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All NSE/ANTHEM market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

143

Groups with data

Currency

INR

Showing 143 of 143 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Employees	1,825
Enterprise value	INR 431.4B
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Biotechnology
Isin	INE0CZ201020
Last refreshed	2026-05-10
Market cap	INR 440.7B
Price	INR 784
Price currency	INR
Rev Per Employee	10,200,828.83x
Sector	Healthcare
Sic	8731
Symbol	nse/ANTHEM
Website	https://anthembio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	1.1%
EV Earnings	89.02x
EV/EBIT	67.05x
EV/EBITDA	58.43x
EV/Sales	21.55x
Forward P/E	65.96x
P/B ratio	16.01x
P/E ratio	91.49x
P/S ratio	22.01x
PEG ratio	2.75x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	32.13%
EBITDA Margin	36.8%
Gross margin	59.49%
Gross Profit	INR 11.9B
Gross Profit Growth	16.61%
Gross Profit Growth Q	5.83%
Net Income	INR 4.8B
Net Income Growth	2.3%
Net Income Growth Q	-25.35%
Net Income Growth Years	0%
Pretax Margin	36.19%
Profit Margin	24.2%
Profit Per Employee	INR 2.5M
Profitable Years	1
ROIC	23.51
Roic5y	37.01

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS Growth	1.78
EPS Growth Q	-25.79
EPS Growth Years	0
Revenue Growth	12.68x
Revenue Growth Q	-15x
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Cash	INR 10.3B
Debt	INR 1.1B
Debt EBITDA	INR 0.15
Debt Equity	INR 0.04
Equity	INR 27.5B
Interest Coverage	123.7
Net Cash	INR 9.2B
Net Cash By Market Cap	INR 2.09
Net Debt EBITDA	INR -1.25
Net Debt Equity	INR -0.33
Tangible Book Value	INR 27.5B
Tangible Book Value Per Share	INR 48.99

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.54%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
50-day SMA	699
All Time High	873.5
All Time High Change	-10.2%
All Time High Date	2025-09-18
All Time Low	579.2
All Time Low Change	35.44%
All Time Low Date	2026-02-02
ATR	23.23
Beta1y	0.69
Ch YTD	20.4
High	805
High52	873.5
High52 Date	2025-09-18
High52ch	-10.2%
Low	779.5
Low52	579.2
Low52 Date	2026-02-02
Low52ch	35.44%
Ma50ch	12.22%
RSI	68.98
RSI Monthly	0
RSI Weekly	62.29
Sharpe ratio	0.32x
Sortino ratio	0.72
Total Return	-0.54%
Tr YTD	20.4
Tr1m	17.57%
Tr1w	2.64%
Tr3m	20.14%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	INR 6.4B
Operating Income Growth	19.3
Operating Income Growth Q	-11.9
Operating margin	32.13

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	61,924,520%
Shares Insiders	80.41%
Shares Institutions	10.85%
Shares Out	561,610,051
Shares Qo Q	-0.14%
Shares Yo Y	0.54%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	329,134.9x
Bv Per Share	49.04
Ch1m	17.57
Ch1w	2.64
Ch3m	20.14
Ch6m	12.61
Change	0.64%
Change From Open	0.15
Close	779.5
Days Gap	0.48
Depreciation Amortization	934,173,500
Dollar Volume	336,789,199.6
Earnings Date	2026-06-24
EBIT	INR 6.4B
EBITDA	INR 7.4B
EPS	INR 8.58
F Score	2
Fiscal Year End	March
Founded	2,006
Graham Number	97.28112
Graham Upside	-87.6
Income Tax	INR 2.4B
Is Primary Listing	1
Last Earnings Date	2026-02-05
Last Report Date	2025-12-31
Ma150	684.1
Ma150ch	14.65%
Ma20	750.4
Ma20ch	4.53%
Next Earnings Date	2026-06-24
Open	783.2
Position In Range	19.37
Price Date	2026-05-08
Price EBITDA	INR 59.8
Ptbv Ratio	16.03
Relative Volume	1.17x
Revenue	20,024,227,000x
Tax By Revenue	11.98x
Tax Rate	33.12%
Tr6m	12.61%
Volume	429,359

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does NSE/ANTHEM pay a dividend?

Capital-return profile for this ticker.

Ownership

Who owns NSE/ANTHEM?

Insider, institutional, and short-interest positioning.

Institutional ownership

+10.8%

Share of float held by funds and institutions

Insider ownership

+80.4%

Stake held by company insiders. Higher generally signals alignment.

Short interest

n/a

Float sold short by bearish positioning

Y/Y dilution

+0.5%

Negative means the company is buying back shares.

Technical

NSE/ANTHEM momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

69.0

Neutral momentum band

Price vs 200-day MA

n/a

50/200-day relationship not available

Beta (5Y)

n/a

Sensitivity to the broader market

Sharpe ratio

0.32

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About NSE/ANTHEM

Hub-level FAQ points readers to the deeper analysis pages.

What is the current nse/ANTHEM stock rating?

nse/ANTHEM is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full nse/ANTHEM analysis?

The full report lives at /stocks/nse/ANTHEM/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for nse/ANTHEM?

The latest report frames nse/ANTHEM around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the nse/ANTHEM page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.